Network pharmacology-based study on mechanisms of Huanglian Jiedu Decoction impact on macrophage inflammation response
(2.Jiangsu Province Key Laboratory of High Technology Research, Nanjing University of Chinese Medicine, Nanjing, China 210023)
【Abstract】This study was designed to explore the impact of Huanglian Jiedu Decoction (HLJDT) on macrophage inflammation reaction using the network pharmacology method. Glycolysis, sphingolipid metabolism and glutamine metabolism were also investigated for “multi-component, multi-target and multi-pathway”, which supports a foundation for drug innovative research. The TCMSP database was used to screen the active components of HLJDT, the target protein predicted by Pharm Mapper database and the DAVID database for pathways annotation and analysis. The Cytoscape 3.2.1 software was used to construct the active component target–pathway network map and GENEMANIA database for protein interaction analysis. System Dock Database Site is used in verification of molecular docking. The results showed that 84 active ingredients were screened in HLJDT with a total of 111 target targets. Fourteen pathways are affected according to 13 macrophage-related inflammatory proteins, and 8 pathways including 34 target proteins from glycolysis, sphingolipid metabolism and glutamine metabolism. Inflammation-related proteins and metabolism-related proteins can interact with each other through physical correlation, protein co-expression, etc. Berberine, baicalin and geniposide combined well with 5 important targets. Huanglian Jiedu Decoction may act on the glycolysis and sphingolipid pathways to regulate macrophage inflammatory responses.
【Keywords】 network pharmacology; Huanglian Jiedu Decoction; inflammation; metabolism;
 Liu AL, Du GH. Network pharmacology: new guidelines for drug discovery [J]. Acta Pharm Sin (药学学报), 2010, 45: 1472–1477.
 Liu ZH, Sun XB. Network pharmacology: new opportunity for the modernization of traditional Chinese medicine [J]. Acta Pharm Sinica (药学学报), 2012, 47: 696–703.
 Wang PR, Wang JS, Yang MH, et al. Neuroprotective effects of Huang-Lian-Jie-Du-Decoction on ischemic stroke rats revealed by H NMR metabolomics approach [J]. J Pharm Biomed Anal, 2014, 88: 106–116.
 Hsu YL, Kuo PL, Tzeng TF, et al. Huang-lian-jie-du-tang, a traditional Chinese medicine prescription, induces cell-cycle arrest and apoptosis in human liver cancer cells in vitro and in vivo [J]. Gastroenterol Hepatol, 2008, 23: 290–299.
 Zhang XJ, Deng YX, Shi QZ, et al. Hypolipidemic effect of the Chinese polyherbal Huanglian Jiedu decoction in type 2 diabetic rats and its possible mechanism [J]. Phytomedicine, 2014, 21: 615–623.
 Hu Y, Hu Z, Wang S, et al. Protective effects of Huang-LianJie-Du-Tang and its component group on collagen-induced arthritis in rats [J]. Ethnopharmacol, 2013, 150: 1137–1144.
 Sun LM, Liu LF, Zhu HX, et al. Network pharmacology based study on intervention mechanism of Huanglian Jiedu decoction in the treatment of Alzheimer's disease [J]. Acta Pharm Sin (药学学报), 2017, 52: 1268–1275.
 Hsin KY, Ghosh S, Kitano H. Combining machine learning systems and multiple docking simulation packages to improve docking prediction reliability for network pharmacology [J]. PLoS One, 2013, 8: e83922.
 Qian ZL, Li H, Zhu HX, et al. Preliminary study on the correlation between pharmacokinetics and pharmacodynamics of index components in Huanglian Jiedu decoction [J]. Chin J Exp Form (中国实验方剂学杂志), 2011, 17: 122–128.
 Xiao YL, Lu FE, Xu LJ, et al. Effect of Huanglian Jiedu decoction on vascular endothelial function in type 2 diabetic rats [J]. China J Chin Mater Med (中国中药杂志), 2005, 30: 1767–1770.
 Ma YL, Wang BB, Han JY, et al. Effect of Huanglian Jiedu decoction on local and aortic vascular local immune response in high-fat diet Apo E-/-mice [J]. Chin J Integr Tradit Chin Western Med (中国中西医结合杂志), 2013, 33: 1520–1525.
 Sun Y, Wang JP, Zhang YL, et al. The inhibitory effect of Huanglian Jiedu Tang on mouse S180 transplanted tumor [J]. J Northeast Agric Univ (东北农业大学学报), 2013, 44: 63–67.
 Peng SL, Liu LF, Zhu HX, et al. Effects of combination drugs and Huanglian Jiedu decoction on the bioactivity of berberine in rat brain [J]. Chin Tradit Herb Drugs (中草药), 2016, 47: 2877–2882.
 Ho YT, Yang JS, Li TC, et al. Berberine suppresses in vitro, migration and invasion of human SCC-4 tongue squamous cancer cells through the inhibitions of FAK, IKK, NF-κB, u-PA and MMP-2 and-9 [J]. Cancer Lett, 2009, 279: 155–162.
 Bae DS, Kim YH, Pan CH, et al. Protopine reduces the inflammatory activity of lipopolysaccharide-stimulated murine macrophages [J]. BMB Rep, 2012, 45: 108–113.
 Akhter MH, Sabir M, Bhide NK. Possible mechanism of antidiarrhoeal effect of berberine [J]. Indian J Med Res, 1979, 70: 233–241.
 Guo C. Berberine Improves Insulin Resistance by Inhibiting Infiltration of Adipose Tissue Macrophages (小檗碱通过抑制脂肪组织巨噬细胞浸润改善胰岛素抵抗的研究) [D]. Nanjing: Nanjing Univ Chin Med, 2015.
 Curi TC, Melo MP, Azevedo RB, et al. Glutamine utilization by rat neutrophils: presence of phosphate dependent glutaminase [J]. Am J Physiol, 1997, 273: 1124–1129.
 Yassad A, Lavoinne A, Bion A, et al. Glutamine accelerates IL-6 production by rat peritoneal macrophages in culture [J]. FEBS Lett, 1997, 413: 81–84.
 Jin J. Analysis of Chemical Constituents of Huanglian Jiedu Decoction and Its Effect on Anti-hyperlipidemia (黄连解毒汤化学成分分析及其抗高脂血症作用的研究) [D]. Changchun: Jilin University, 2008.
 Liu Y, Lou SY, He YM, et al. Effects of berberine on the proliferation and differentiation-related genes PPARγC/EBPα m RNA and protein expression in 3T3-L1 preadipocytes [J]. Chin J Integr Tradit Chin Western Med (中国中西医结合杂志), 2008, 28: 1005–1009.
 Piao CL, Yang SY, Tong XL, et al. Discussion on prevention and treatment of obesity type 2 diabetes by Chinese medicine from the mechanism of adipose tissue inflammation [J]. JRehabil (康复学报), 2009, 19: 61–63.
 He X, Huang Y, Li B, et al. Deregulation of sphingolipid metabolism in Alzheimer's disease [J]. Neurobiol Aging, 2010, 31: 398–408.
 Gemma C, Smith MA, Samar B, et al. Increased isoprostane and prostaglandin are prominent in neurons in Alzheimer disease [J]. Mol Neurodegener, 2007, 2: 2.
 Haughey NJ, Bandaru VV, Bae M, et al. Roles for dysfunctional sphingolipid metabolism in Alzheimer's disease neuropathogenesis [J]. Biochim Biophys Acta, 2010, 1801: 878–886.
 Hannun YA, Obeid LM. The ceramide-centric universe of lipid-mediated cell regulation:stress encounters of the 1ipid kind [J]. J Biol Chem, 2002, 277: 25847–25850.
 Nakao S, Moriyama S, Segawa M, et al. C-2-ceramide inhibits the prostaglandin E-2-induced accumulation of c AMP in human gingival fibroblasts [J]. Mol Cancer Ther, 2010, 9: 1378–1395.
 Ballou LR, Laulederkind SJ, Rosloniec EF, et al. Ceramide signalling and the immune response [J]. Biochim Biophys Acta, 1996, 1301: 273–287.
 Cutler RG, Kelly J, Storie K, et al. Involvement of oxidative stress-induced abnormalities in ceramide and cholesterol metabolism in brain aging and Alzheimer's disease [J]. Proc Nat Acad Sci U S A, 2004, 101: 2070–2075.
 Sun LM, Zhu BJ, Cao HT, et al. Explore the effects of Huang-Lian-Jie-Du-Tang on Alzheimer’s disease by UPLC-QTOF/MS-based plasma metabolomics study [J]. J Pharm Biomed Anal, 2017, 151: 75–83.
 Sun GL, Sun W, Lan Q, et al. The sphingomyelin metabolism of cerebral ischemia [J]. Prog Mod Biomed (现代生物医学进展), 2015, 15: 1566–1569.
 Zhang QC, Bian HM, Guo LW, et al. Berberine preconditioning protects neurons against ischemia via sphingosine-1-phosphate and hypoxia-inducible factor-1α [J]. Am J Chin Med, 2016, 44: 927–941.
 Murphy CJ, Newsholme P. Importance of glutamine metabolism in murine macrophages and human monocytes to L-arginine biosynthesis and rates of nitrite or urea production [J]. Clin Sci, 1998, 95: 397–407.
 Ziegler TR, Daignault NM.Glutamine regulation of human immune cell function [J]. Nutrition, 2000, 16: 458–459.